AbbVie’s Parkinson’s disease drug improves mobility in patients in late-stage study

AbbVie's experimental drug to treat early-stage Parkinson's disease has helped significantly improve patients' ability to perform everyday tasks such as eating and walking, months after the drug maker revealed its…

Continue ReadingAbbVie’s Parkinson’s disease drug improves mobility in patients in late-stage study

AbbVie’s Parkinson’s disease drug improves mobility in patients in late-stage study

AbbVie's experimental drug to treat early-stage Parkinson's disease has helped significantly improve patients' ability to perform everyday tasks such as eating and walking, months after the drug maker revealed its…

Continue ReadingAbbVie’s Parkinson’s disease drug improves mobility in patients in late-stage study